Cargando…

Maxadilan Prevents Apoptosis in iPS Cells and Shows No Effects on the Pluripotent State or Karyotype

Pituitary adenylate cyclase-activating polypeptide (PACAP) is a structurally endogenous peptide with many biological roles. Maxadilan, a 61-amino acid vasodilatory peptide, specifically activates the PACAP type I receptor (PAC1). Although PAC1 has been identified in embryonic stem cells, little is k...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Zhiyi, Yu, Rongjie, Yang, Jiayin, Liu, Xiaofei, Tan, Meihua, Li, HongYang, Chen, Jiansu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3311553/ https://www.ncbi.nlm.nih.gov/pubmed/22457805 http://dx.doi.org/10.1371/journal.pone.0033953

Ejemplares similares

PAC1R agonist maxadilan enhances hADSC viability and neural differentiation potential
por: Guo, Xiaoling, et al.
Publicado: (2016)

Modulation of Pluripotency in the Porcine Embryo and iPS Cells
por: Rodríguez, Aida, et al.
Publicado: (2012)

Preclinical evaluation of PAC1 targeting with radiolabeled Maxadilan
por: Joosten, Lieke, et al.
Publicado: (2017)

Generation of Induced Pluripotent Stem (iPS) Cells by Nuclear Reprogramming
por: Dey, Dilip, et al.
Publicado: (2011)

Induced pluripotent stem (iPS) cells: an up-to-the-minute review
por: Lau, Frank, et al.
Publicado: (2009)

Metformin limits the tumourigenicity of iPS cells without affecting their pluripotency
por: Vazquez-Martin, Alejandro, et al.
Publicado: (2012)

Induced Pluripotent Stem (iPS) Cells in Dentistry: A Review
por: Malhotra, Neeraj
Publicado: (2016)

Distinct iPS Cells Show Different Cardiac Differentiation Efficiency
por: Ohno, Yohei, et al.
Publicado: (2013)

An ES-Like Pluripotent State in FGF-Dependent Murine iPS cells
por: Di Stefano, Bruno, et al.
Publicado: (2010)

Beyond iPS!
Publicado: (2012)

DNA repair and replication links to pluripotency and differentiation capacity of pig iPS cells
por: Liu, Kai, et al.
Publicado: (2017)

Aging in iPS cells
por: Miller, Justine, et al.
Publicado: (2014)

Myogenic Differentiation of iPS Cells Shows Different Efficiency in Simultaneous Comparison of Protocols
por: Ulman, Aleksandra, et al.
Publicado: (2021)

Protective effects of human iPS-derived retinal pigmented epithelial cells on retinal degenerative disease
por: Zhu, Deliang, et al.
Publicado: (2020)

Induced pluripotent stem cells (iPS) derived disease models: In vivo to in vitro gaps
Publicado: (2018)

Profiling the microRNA Expression in Human iPS and iPS-derived Retinal Pigment Epithelium
por: Wang, Heuy-Ching, et al.
Publicado: (2014)

Correction: Protective effects of human iPS-derived retinal pigmented epithelial cells on retinal degenerative disease
por: Zhu, Deliang, et al.
Publicado: (2022)

Understanding the mysteries of iPS cells
por: Cohen, Justin Brent, et al.
Publicado: (2009)

Evolving science enhanced with iPS
Publicado: (2007)

iPS Cells—The Triumphs and Tribulations
por: Sharma, Riddhi
Publicado: (2016)

Induced pluripotent stem (iPS) cells offer a powerful new tool for the life sciences
por: Nakamura, Y
Publicado: (2010)

Acetylation-dependent regulation of essential iPS-inducing factors: a regulatory crossroad for pluripotency and tumorigenesis
por: Dai, Xiangpeng, et al.
Publicado: (2014)

Lineage conversion induced by pluripotency factors involves transient passage through an iPS cell stage
por: Bar-Nur, Ori, et al.
Publicado: (2015)

The novel application of cordycepin in maintaining stem cell pluripotency and increasing iPS cell generation efficiency
por: Wang, Chie-Hong, et al.
Publicado: (2020)

Highly Effective Protocol for Differentiation of Induced Pluripotent Stem Cells (iPS) into Melanin-Producing Cells
por: Sułkowski, Maciej, et al.
Publicado: (2021)

Telomere Reprogramming and Maintenance in Porcine iPS Cells
por: Ji, Guangzhen, et al.
Publicado: (2013)

An HDAC2-TET1 switch at distinct chromatin regions significantly promotes the maturation of pre-iPS to iPS cells
por: Wei, Tingyi, et al.
Publicado: (2015)

BAM15 attenuates transportation-induced apoptosis in iPS-differentiated retinal tissue
por: Tang, Mingjun, et al.
Publicado: (2019)

A protocol for metabolic characterization of human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM)
por: House, Alisha, et al.
Publicado: (2019)

Generation of Human Induced Pluripotent Stem (iPS) Cells in Serum- and Feeder-Free Defined Culture and TGF-β1 Regulation of Pluripotency
por: Yamasaki, Sachiko, et al.
Publicado: (2014)

The Potential of iPS Cells in Synucleinopathy Research
por: Linta, Leonhard, et al.
Publicado: (2012)

The tumourigenicity of iPS cells and their differentiated derivates
por: Liu, Zhiqiang, et al.
Publicado: (2013)

iPS-Cinderella Story in Cell Biology
Publicado: (2010)

Modeling Kidney Disease with iPS Cells
por: Freedman, Benjamin S.
Publicado: (2015)

Questions Surrounding iPS Cells in Japan
por: Yui, Yoshiki
Publicado: (2016)

iPS‐derived pericytes for neurovascular regeneration
por: Kirabali, Tunahan, et al.
Publicado: (2021)

Establishment of LIF-Dependent Human iPS Cells Closely Related to Basic FGF-Dependent Authentic iPS Cells
por: Hirai, Hiroyuki, et al.
Publicado: (2012)

Ethanol-mediated activation of the NLRP3 inflammasome in iPS cells and iPS cells-derived neural progenitor cells
por: De Filippis, Lidia, et al.
Publicado: (2016)

First‐in‐human development of a pharmacodynamic biomarker for PAC(1) receptor antagonists using intradermal injections of maxadilan
por: Marynissen, Heleen, et al.
Publicado: (2022)

Small RNA-mediated regulation of iPS cell generation
por: Li, Zhonghan, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_chvsnhv60bdp3mrcjddocqft42